Results 221 to 230 of about 205,694 (360)
Assessment of the prescription of red blood cell concentrates in the pediatric age group [PDF]
João Carlos Pina Faria +3 more
openalex +1 more source
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu +10 more
wiley +1 more source
Improving Plant Growth Under a Luminescent Solar Concentrator Emitting Red Light. [PDF]
Pertesi M +9 more
europepmc +1 more source
NKCC1: A key regulator of glioblastoma progression
Glioblastoma (GBM) progression is driven by disrupted chloride cotransporter homeostasis. NKCC1 is highly expressed in stem‐like, astrocytic, and progenitor cells, correlating with earlier recurrence, while overall survival remains unaffected. NKCC1 serves as a prognostic marker and potential therapeutic target, linking chloride transporter imbalance ...
Anja Thomsen +5 more
wiley +1 more source
Pushing the Detailed Balance Limit in III-V Semiconductor Photoconversion with Bandgap-Engineering Multijunction Architectures. [PDF]
Gao X +6 more
europepmc +1 more source
Anells concentrics = Concentric rings
Gausa, Manuel, Bernadó Tarragona, Jordi
openaire +1 more source
Exit and Survival in a Concentrating Industry: The Case of Daily Newspapers in the Netherlands
H.L. van Kranenburg +2 more
openalex +2 more sources
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak +10 more
wiley +1 more source
Investigation of Fenbendazole Solubility Using Particle Size Reduction Methods in the Presence of Soluplus<sup>®</sup>. [PDF]
Karimi A +6 more
europepmc +1 more source

